Exploring the Prognosis of Breast Cancer with Synchronous Distant Nonregional Lymph Node Metastasis and Establishing a Predictive Model: A Population-Based Study

Figure 2

KM curves for patients with diverse stages in different populations ((a) for all included patients; (b) luminal A subtype; (c) luminal B subtype; (d) Her2 + HR- subtype; (e) TNBC subtype). SDLNM: synchronous isolated distant lymph node metastasis; Her2: human epidermal growth factor receptor type 2; HR: hormone receptor; TNBC: triple-negative breast cancer.

(a)

(b)

(c)

(d)

(e)